Rallybio Corp

Ownership Transactions Reported by 20 Insiders

Symbol
RLYB on Nasdaq
Industry
Pharmaceutical Preparations
Location
234 Church Street, Suite 1020, New Haven, CT

There are no Buy or Sell transactions made by insiders since 4/23/2024

Rallybio Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Viking Global Investors Lp 10%+ Owner $20M Nov 15, 2022
5AM Opportunities I, L.P. 10%+ Owner $19.4M Jun 3, 2022
5AM Partners V, LLC 10%+ Owner $18.9M Mar 7, 2023
5AM Ventures V, L.P. 10%+ Owner $14.5M Jul 29, 2021
Timothy M. Shannon Director $12.6M Jan 3, 2022
Fmr Llc Other* $8.83M Aug 2, 2021
Martin Mackay Director $447K Jan 2, 2025
Jeffrey M. Fryer Chief Financial Officer & Treasurer $355K Mar 21, 2022
Stephen Uden Chief Executive Officer, Director $318K Feb 14, 2025
Jonathan I. Lieber Chief Financial Officer $126K Feb 14, 2025
Steven Ryder Chief Medical Officer $126K Feb 14, 2025
Robert Lorne Hopfner Director $80.7K Jan 2, 2025
Ronald Hunt Director $80.7K Jan 2, 2025
Hui Liu Director $76.7K Jan 2, 2025
Christine A. Nash Director $29.2K May 15, 2024
Kush Parmar Director $29.2K May 15, 2024
Wendy Chung Director $29.2K May 15, 2024
Paula Soteropoulos Director $29.2K May 15, 2024
Helen M. Boudreau Director $29.2K May 15, 2024
Lucian Iancovici Director Jul 29, 2021

Recent Insider Transactions by Companies or Individuals for Rallybio Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.